888 Reaffirms Maintains Rating for argenx (NASDAQ:ARGX)

888 reaffirmed their maintains rating on shares of argenx (NASDAQ:ARGX – Get Rating) in a research note published on Friday, Benzinga reports. A number of other equities analysts have also issued reports on ARGX. Truist Financial increased their price objective on argenx from $420.00 to $440.00 in a report on Friday. JMP Securities decreased their […]

Related Keywords

Germany ,Japan ,Belgium ,United States ,Switzerland ,Netherlands ,France ,America , ,Us Bancorp ,Nasdaq ,Raymond James Financial Services Advisors Inc ,Raymond James Associates ,York Mellon Corp ,Immunology Innovation Program ,Jpmorgan Chase Co ,Company Profile ,Get Rating ,Moderate Buy ,James Financial Services Advisors ,New York Mellon Corp ,Argenx ,Nasdaq Argx ,Argx ,Medical ,Reiterated Rating ,888 Holdings Plc ,